{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T14:15:14Z","timestamp":1783433714551,"version":"3.54.6"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004479","name":"Jiangxi Natural Science Foundation","doi-asserted-by":"crossref","award":["20232BAB216073"],"award-info":[{"award-number":["20232BAB216073"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82260194"],"award-info":[{"award-number":["82260194"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Key Projects of Jiangxi Administration of Traditional Chinese Medicine","award":["GZY-KJS-2023-028"],"award-info":[{"award-number":["GZY-KJS-2023-028"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-025-03892-x","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T11:58:40Z","timestamp":1752926320000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Unveiling the power of plumbagin: revitalizing exhausted T cells to combat tongue cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Rongrong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingkun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runying","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxuan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,19]]},"reference":[{"key":"3892_CR1","doi-asserted-by":"publisher","unstructured":"Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. May 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","DOI":"10.3322\/caac.21834"},{"key":"3892_CR2","doi-asserted-by":"publisher","unstructured":"Chen J, et al. Progress in the study of long noncoding RNA in tongue squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. Jan. 2020;129(1):51\u201358, https:\/\/doi.org\/10.1016\/j.oooo.2019.08.011","DOI":"10.1016\/j.oooo.2019.08.011"},{"key":"3892_CR3","doi-asserted-by":"publisher","unstructured":"Da Silva Souto AC, et al. Epidemiology of tongue squamous cell carcinoma: A retrospective cohort study. Oral Dis. Mar. 2023;29(2):402\u2013410. https:\/\/doi.org\/10.1111\/odi.13897","DOI":"10.1111\/odi.13897"},{"key":"3892_CR4","unstructured":"Aktar N, et al. Understanding of immune escape mechanisms and advances in Cancer immunotherapy. J Oncol."},{"key":"3892_CR5","doi-asserted-by":"publisher","unstructured":"Zhou B, et al. A role for cancer-associated fibroblasts in inducing the epithelial\u2010to\u2010mesenchymal transition in human tongue squamous cell carcinoma. J Oral Pathol Med. Sep. 2014;43(8):585\u2013592. https:\/\/doi.org\/10.1111\/jop.12172","DOI":"10.1111\/jop.12172"},{"key":"3892_CR6","doi-asserted-by":"publisher","unstructured":"De Visser KE, Joyce JA. The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth. Cancer Cell. Mar. 2023;41(3):374\u2013403. https:\/\/doi.org\/10.1016\/j.ccell.2023.02.016","DOI":"10.1016\/j.ccell.2023.02.016"},{"key":"3892_CR7","doi-asserted-by":"publisher","unstructured":"Blank CU, et al. Defining \u2018T cell exhaustion\u2019. Nat Rev Immunol. Nov. 2019;19(11):665\u201374. https:\/\/doi.org\/10.1038\/s41577-019-0221-9","DOI":"10.1038\/s41577-019-0221-9"},{"key":"3892_CR8","doi-asserted-by":"publisher","unstructured":"Yang R, et al. Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy. Nat Commun. Feb. 2021;12(1):832. https:\/\/doi.org\/10.1038\/s41467-021-21099-2.","DOI":"10.1038\/s41467-021-21099-2"},{"key":"3892_CR9","doi-asserted-by":"publisher","unstructured":"Giraldo NA, et al. The immune contexture of primary and metastatic human tumours. Curr Opin Immunol. Apr. 2014;27:8\u201315. https:\/\/doi.org\/10.1016\/j.coi.2014.01.001.","DOI":"10.1016\/j.coi.2014.01.001"},{"key":"3892_CR10","doi-asserted-by":"publisher","unstructured":"Sakuishi K, et al. Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J Exp Med. Sep. 2010;207(10):2187\u20132194. https:\/\/doi.org\/10.1084\/jem.20100643","DOI":"10.1084\/jem.20100643"},{"key":"3892_CR11","doi-asserted-by":"publisher","unstructured":"Oliveira G, Wu CJ. Dynamics and specificities of T cells in cancer immunotherapy. Nat Rev Cancer. May 2023;23(5):295\u2013316. https:\/\/doi.org\/10.1038\/s41568-023-00560-y.","DOI":"10.1038\/s41568-023-00560-y"},{"key":"3892_CR12","doi-asserted-by":"publisher","unstructured":"Feh\u00e9rvari Z, Sakaguchi S. CD4\u2009+\u2009Tregs and immune control. J Clin Invest. Nov. 2004;114(9):1209\u20131217. https:\/\/doi.org\/10.1172\/JCI200423395","DOI":"10.1172\/JCI200423395"},{"key":"3892_CR13","doi-asserted-by":"publisher","unstructured":"Jiang X, Shapiro DJ. The immune system and inflammation in breast cancer. Mol Cell Endocrinol. 2014;382(1):673\u201382. https:\/\/doi.org\/10.1016\/j.mce.2013.06.003","DOI":"10.1016\/j.mce.2013.06.003"},{"key":"3892_CR14","doi-asserted-by":"publisher","unstructured":"Gerber AL, et al. High expression of FOXP3 in primary melanoma is associated with tumour progression. Br J Dermatol. Jan. 2014;170(1):103\u2013109. https:\/\/doi.org\/10.1111\/bjd.12641","DOI":"10.1111\/bjd.12641"},{"key":"3892_CR15","doi-asserted-by":"publisher","unstructured":"Zhang Y, Liang Y, He C. Anticancer activities and mechanisms of heat-clearing and detoxicating traditional Chinese herbal medicine. Chin Med. Dec. 2017;12(1). https:\/\/doi.org\/10.1186\/s13020-017-0140-2.","DOI":"10.1186\/s13020-017-0140-2"},{"key":"3892_CR16","doi-asserted-by":"publisher","unstructured":"Zheng H, et al. Traditional Chinese medicine inhibits PD-1\/PD-L1 axis to sensitize cancer immunotherapy: a literature review. Front Oncol. Jun. 2023;13:1168226. https:\/\/doi.org\/10.3389\/fonc.2023.1168226.","DOI":"10.3389\/fonc.2023.1168226"},{"key":"3892_CR17","doi-asserted-by":"publisher","unstructured":"Huo J-L, et al. Research advance of natural products in tumor immunotherapy. Front Immunol. Sep. 2022;13:972345. https:\/\/doi.org\/10.3389\/fimmu.2022.972345.","DOI":"10.3389\/fimmu.2022.972345"},{"key":"3892_CR18","doi-asserted-by":"publisher","unstructured":"Tripathi SK, et al. Emerging role of plumbagin: cytotoxic potential and pharmaceutical relevance towards cancer therapy. Food Chem Toxicol. Mar. 2019;125:566\u201382. https:\/\/doi.org\/10.1016\/j.fct.2019.01.018.","DOI":"10.1016\/j.fct.2019.01.018"},{"key":"3892_CR19","doi-asserted-by":"publisher","unstructured":"Pai SA, et al. Plumbagin reduces obesity and nonalcoholic fatty liver disease induced by fructose in rats through regulation of lipid metabolism, inflammation and oxidative stress. Biomed Pharmacother. Mar. 2019;111:686\u2013694. https:\/\/doi.org\/10.1016\/j.biopha.2018.12.139","DOI":"10.1016\/j.biopha.2018.12.139"},{"key":"3892_CR20","doi-asserted-by":"publisher","unstructured":"Xue D, et al. Cytotoxicity mechanisms of plumbagin in drug-resistant tongue squamous cell carcinoma. J Pharm Pharmacol. 2021 Mar;73(1):98-109. https:\/\/doi.org\/10.1093\/jpp\/rgaa027","DOI":"10.1093\/jpp\/rgaa027"},{"key":"3892_CR21","doi-asserted-by":"publisher","unstructured":"Zhang R, et al. Suppressive effects of Plumbagin on the growth of human bladder cancer cells via PI3K\/AKT\/mTOR signaling pathways and EMT. Cancer Cell Int. Dec. 2020;20(1):520. https:\/\/doi.org\/10.1186\/s12935-020-01607-y.","DOI":"10.1186\/s12935-020-01607-y"},{"key":"3892_CR22","doi-asserted-by":"publisher","unstructured":"Xue D, et al. ROS enhances the cytotoxicity of cisplatin by inducing apoptosis and autophagy in tongue squamous cell carcinoma cells. Int J Biochem Cell Biol. May 2020;122:105732. https:\/\/doi.org\/10.1016\/j.biocel.2020.105732.","DOI":"10.1016\/j.biocel.2020.105732"},{"key":"3892_CR23","doi-asserted-by":"publisher","unstructured":"Na S et al. Plumbagin-mediating GLUT1 suppresses the growth of human tongue squamous cell carcinoma, https:\/\/doi.org\/10.1111\/odi.12799","DOI":"10.1111\/odi.12799"},{"key":"3892_CR24","doi-asserted-by":"publisher","unstructured":"Jiang Z-B, et al. Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8\u2009+\u2009T cells. Pharmacol Res. Jul. 2021;169:105656. https:\/\/doi.org\/10.1016\/j.phrs.2021.105656.","DOI":"10.1016\/j.phrs.2021.105656"},{"key":"3892_CR25","doi-asserted-by":"publisher","unstructured":"Poosarla A, et al. Modulation of T cell proliferation and cytokine response by plumbagin, extracted from Plumbago zeylanica in collagen induced arthritis. BMC Complement Altern Med. Dec. 2011;11(1):114. https:\/\/doi.org\/10.1186\/1472-6882-11-114.","DOI":"10.1186\/1472-6882-11-114"},{"key":"3892_CR26","doi-asserted-by":"publisher","unstructured":"Qiu L, et al. Exosomes of oral squamous cell carcinoma cells containing miR-181a-3p induce muscle cell atrophy and apoptosis by transmissible endoplasmic reticulum stress signaling. Biochem Biophys Res Commun. Dec. 2020;533(4):831\u2013837. https:\/\/doi.org\/10.1016\/j.bbrc.2020.09.066","DOI":"10.1016\/j.bbrc.2020.09.066"},{"key":"3892_CR27","doi-asserted-by":"publisher","unstructured":"Park JW, et al. High antiangiogenic and low anticoagulant efficacy of orally active low molecular weight heparin derivatives. J Controlled Release. Dec. 2010;148(3):317\u201326. https:\/\/doi.org\/10.1016\/j.jconrel.2010.09.014.","DOI":"10.1016\/j.jconrel.2010.09.014"},{"key":"3892_CR28","doi-asserted-by":"publisher","unstructured":"Jin S, et al. The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKK\u03b5\/TBK1\/IRF3 pathway in head and neck squamous cell carcinoma. Mol Cancer. Dec. 2022;21(1):97. https:\/\/doi.org\/10.1186\/s12943-022-01572-2","DOI":"10.1186\/s12943-022-01572-2"},{"key":"3892_CR29","doi-asserted-by":"publisher","unstructured":"Suzuki R, et al. An animal model for the rapid induction of tongue neoplasms in human c-Ha- ras proto-oncogene transgenic rats by 4-nitroquinoline 1-oxide: its potential use for preclinical chemoprevention studies. Carcinogenesis. Mar. 2006;27(3):619\u2013630. https:\/\/doi.org\/10.1093\/carcin\/bgi241","DOI":"10.1093\/carcin\/bgi241"},{"key":"3892_CR30","doi-asserted-by":"publisher","unstructured":"Sur S, et al. Bitter melon prevents the development of 4-NQO\u2013Induced oral squamous cell carcinoma in an immunocompetent mouse model by modulating immune signaling. Cancer Prev Res. Apr. 2018;11(4):191\u2013202. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-17-0237.","DOI":"10.1158\/1940-6207.CAPR-17-0237"},{"key":"3892_CR31","doi-asserted-by":"publisher","unstructured":"Higdon LE, et al. Virtual global transplant laboratory standard operating procedures for blood collection, PBMC isolation, and storage. Transplantation Direct. Sep. 2016;2(9):e101. https:\/\/doi.org\/10.1097\/TXD.0000000000000613.","DOI":"10.1097\/TXD.0000000000000613"},{"key":"3892_CR32","doi-asserted-by":"publisher","unstructured":"Kongkaew T, et al. TIL expansion with high dose IL-2 or low dose IL-2 with anti-CD3\/anti-CD28 stimulation provides different quality of TIL-expanded T cell clones. J Immunol Methods. Apr. 2022;503:113229. https:\/\/doi.org\/10.1016\/j.jim.2022.113229.","DOI":"10.1016\/j.jim.2022.113229"},{"key":"3892_CR33","doi-asserted-by":"publisher","unstructured":"Trickett A, Kwan YL. T cell stimulation and expansion using anti-CD3\/CD28 beads. J Immunol Methods. Apr. 2003;275:1\u20132. https:\/\/doi.org\/10.1016\/S0022-1759(03)00010-3.","DOI":"10.1016\/S0022-1759(03)00010-3"},{"key":"3892_CR34","doi-asserted-by":"publisher","unstructured":"Chakraborty R, et al. STAT3 interactome predicts presence of proteins that regulate immune system in oral squamous cell carcinoma. J Oral Biosci. Dec. 2024;66(4):67\u201373. https:\/\/doi.org\/10.1016\/j.job.2024.09.002.","DOI":"10.1016\/j.job.2024.09.002"},{"issue":"11","key":"3892_CR35","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.ccell.2022.09.013","volume":"40","author":"X Zhang","year":"2022","unstructured":"Zhang X, et al. Depletion of BATF in CAR-T cells enhances antitumor activity by inducing resistance against exhaustion and formation of central memory cells. Cancer Cell. Nov. 2022;40(11):1407\u201322. e7. https:\/\/doi.org\/10.1016\/j.ccell.2022.09.013","journal-title":"Cancer Cell"},{"key":"3892_CR36","doi-asserted-by":"publisher","unstructured":"Steiger L, et al. Protocol for isolation and spectral flow cytometry analysis of immune cells from the murine exocrine and endocrine pancreas. STAR Protocols. Dec. 2023;4(4):102664. https:\/\/doi.org\/10.1016\/j.xpro.2023.102664.","DOI":"10.1016\/j.xpro.2023.102664"},{"key":"3892_CR37","doi-asserted-by":"publisher","unstructured":"Mondrag\u00f3n L, et al. GAPDH overexpression in the T cell lineage promotes angioimmunoblastic T cell lymphoma through an NF-\u03baB-Dependent mechanism. Cancer Cell. Sep. 2019;36(3):268\u201387. https:\/\/doi.org\/10.1016\/j.ccell.2019.07.008.","DOI":"10.1016\/j.ccell.2019.07.008"},{"key":"3892_CR38","doi-asserted-by":"publisher","unstructured":"Kanojia D, Vaidya MM. 4-Nitroquinoline-1-oxide induced experimental oral carcinogenesis. Oral Oncol. Aug. 2006;42(7):655\u201367. https:\/\/doi.org\/10.1016\/j.oraloncology.2005.10.013.","DOI":"10.1016\/j.oraloncology.2005.10.013"},{"key":"3892_CR39","doi-asserted-by":"publisher","unstructured":"Ward FJ, et al. Clonal regulatory T cells specific for a red blood cell autoantigen in human autoimmune hemolytic anemia. Blood. Jan. 2008;111(2):680\u20137. https:\/\/doi.org\/10.1182\/blood-2007-07-101345.","DOI":"10.1182\/blood-2007-07-101345"},{"key":"3892_CR40","doi-asserted-by":"publisher","unstructured":"Morrison PJ, et al. Interleukin-23 and T helper 17-type responses in intestinal inflammation: from cytokines to T-cell plasticity: IL-23 and Th17-type responses in intestinal inflammation. Immunology. Aug. 2011;133(4):397\u2013408. https:\/\/doi.org\/10.1111\/j.1365-2567.2011.03454.x.","DOI":"10.1111\/j.1365-2567.2011.03454.x"},{"key":"3892_CR41","doi-asserted-by":"publisher","unstructured":"Liu L, et al. The effect of Curcumin on multi-level immune checkpoint Blockade and T cell dysfunction in head and neck cancer. Phytomedicine. Nov. 2021;92:153758. https:\/\/doi.org\/10.1016\/j.phymed.2021.153758.","DOI":"10.1016\/j.phymed.2021.153758"},{"key":"3892_CR42","doi-asserted-by":"publisher","unstructured":"Ng JH, et al. Changing epidemiology of oral squamous cell carcinoma of the tongue: A global study. Head Neck. Feb. 2017;39(2):297\u2013304. https:\/\/doi.org\/10.1002\/hed.24589.","DOI":"10.1002\/hed.24589"},{"key":"3892_CR43","doi-asserted-by":"publisher","unstructured":"Deneuve S, et al. Diverging incidence trends of oral tongue cancer compared to other head and neck cancers in young adults in France. Intl Journal of Cancer. Apr. 2022;150(8):1301\u20131309. https:\/\/doi.org\/10.1002\/ijc.33896","DOI":"10.1002\/ijc.33896"},{"key":"3892_CR44","doi-asserted-by":"publisher","unstructured":"Siegel R, et al Cancer statistics, Cancer CAA. Clinicians J. Jan. 2014;64(1):9\u201329. https:\/\/doi.org\/10.3322\/caac.21208","DOI":"10.3322\/caac.21208"},{"key":"3892_CR45","doi-asserted-by":"publisher","unstructured":"Bello IO, et al. Prognostic evaluation of oral tongue cancer: means, markers and perspectives (I). Oral Oncol. Sep. 2010;46(9):630\u20135. https:\/\/doi.org\/10.1016\/j.oraloncology.2010.06.006.","DOI":"10.1016\/j.oraloncology.2010.06.006"},{"key":"3892_CR46","doi-asserted-by":"publisher","unstructured":"Spence RN, et al. Margin distance in oral tongue cancer surgery: A systematic review of survival and recurrence outcomes. Oral Oncol. Dec. 2023;147:106609. https:\/\/doi.org\/10.1016\/j.oraloncology.2023.106609.","DOI":"10.1016\/j.oraloncology.2023.106609"},{"key":"3892_CR47","unstructured":"de Tolentino E, et al. literature review and suggestion of a clinical oral."},{"key":"3892_CR48","doi-asserted-by":"publisher","unstructured":"Mehndiratta S, et al. A review based study on emotional distress and physical pain in oral and head and neck cancer patients pre- and post-chemotherapy. Oral Oncol Rep. Sep. 2024;11:100637. https:\/\/doi.org\/10.1016\/j.oor.2024.100637","DOI":"10.1016\/j.oor.2024.100637"},{"key":"3892_CR49","doi-asserted-by":"publisher","unstructured":"Watters AL, et al. Oral complications of targeted cancer therapies: A narrative literature review. Oral Oncol. Jun. 2011;47(6):441\u2013448. https:\/\/doi.org\/10.1016\/j.oraloncology.2011.03.028","DOI":"10.1016\/j.oraloncology.2011.03.028"},{"key":"3892_CR50","unstructured":"Akisada N. PD-L1 expression in tongue squamous cell carcinoma. Med Mol Morphol."},{"key":"3892_CR51","doi-asserted-by":"publisher","unstructured":"Ravi P, Babu S. Emerging immune checkpoint inhibitors for the treatment of oropharyngeal squamous cell carcinoma. Oral Oncol Rep. Dec. 2024;12:100650. https:\/\/doi.org\/10.1016\/j.oor.2024.100650.","DOI":"10.1016\/j.oor.2024.100650"},{"key":"3892_CR52","doi-asserted-by":"publisher","unstructured":"Ferris RL et al. Nivolumab for Recurrent squamous-cell carcinoma of the head and neck. N Engl J Med. Nov.2016;375(19):1856\u20131867. https:\/\/doi.org\/10.1056\/NEJMoa1602252","DOI":"10.1056\/NEJMoa1602252"},{"key":"3892_CR53","doi-asserted-by":"publisher","unstructured":"Gao M, et al. PD-1 regulation in immune homeostasis and immunotherapy. Cancer Lett. Apr. 2024;588:216726. https:\/\/doi.org\/10.1016\/j.canlet.2024.216726.","DOI":"10.1016\/j.canlet.2024.216726"},{"key":"3892_CR54","doi-asserted-by":"publisher","unstructured":"Sun C, et al. Regulation and function of the PD-L1 checkpoint. Immunity. Mar. 2018;48(3):434\u201352. https:\/\/doi.org\/10.1016\/j.immuni.2018.03.014.","DOI":"10.1016\/j.immuni.2018.03.014"},{"key":"3892_CR55","doi-asserted-by":"publisher","unstructured":"Shen S, et al. Targeting PD-1\/PD-L1 in tumor immunotherapy: mechanisms and interactions with host growth regulatory pathways. Cytokine Growth Factor Rev. Oct. 2024;79:16\u201328. https:\/\/doi.org\/10.1016\/j.cytogfr.2024.08.001.","DOI":"10.1016\/j.cytogfr.2024.08.001"},{"key":"3892_CR56","doi-asserted-by":"publisher","unstructured":"Qiao D-R, et al. PD-L1\/PD-1 blockage enhanced the cytotoxicity of natural killer cell on the non-small cell lung cancer (NSCLC) by granzyme B secretion. Clin Transl Oncol. Mar. 2023;25(8):2373\u20132383. https:\/\/doi.org\/10.1007\/s12094-023-03120-w","DOI":"10.1007\/s12094-023-03120-w"},{"issue":"6","key":"3892_CR57","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.molcel.2021.01.010","volume":"81","author":"M Yu","year":"2021","unstructured":"Yu M, et al. Interferon-\u03b3 induces tumor resistance to anti-PD-1 immunotherapy by promoting YAP phase separation. Mol Cell. 2021;81(6):1216\u201330. https:\/\/doi.org\/10.1016\/j.molcel.2021.01.010.","journal-title":"Mol Cell"},{"key":"3892_CR58","doi-asserted-by":"publisher","unstructured":"Andrews LP, et al. Resistance to PD1 Blockade in the absence of metalloprotease-mediated LAG3 shedding. Sci Immunol. 2020;5(49):eabc2728. https:\/\/doi.org\/10.1126\/sciimmunol.abc2728","DOI":"10.1126\/sciimmunol.abc2728"},{"key":"3892_CR59","doi-asserted-by":"publisher","unstructured":"Ozkazanc D, et al. Functional exhaustion of CD4+ T cells induced by co-stimulatory signals from myeloid leukaemia cells. Immunology, Dec.2016;149(4):460\u2013471. https:\/\/doi.org\/10.1111\/imm.12665","DOI":"10.1111\/imm.12665"},{"key":"3892_CR60","doi-asserted-by":"publisher","unstructured":"Kujan O, et al. Immune checkpoint inhibitors in oral cavity squamous cell carcinoma and oral potentially malignant disorders: a systematic review. Cancers. Jul. 2020;12(7):1937. https:\/\/doi.org\/10.3390\/cancers12071937","DOI":"10.3390\/cancers12071937"},{"key":"3892_CR61","doi-asserted-by":"publisher","unstructured":"Josefowicz SZ, et al. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol. Apr. 2012;30(1):531\u2013564. https:\/\/doi.org\/10.1146\/annurev.immunol.25.022106.141623","DOI":"10.1146\/annurev.immunol.25.022106.141623"},{"key":"3892_CR62","doi-asserted-by":"publisher","unstructured":"Josefowicz SZ, Rudensky A. Control of regulatory T cell lineage commitment and maintenance. Immunity. 2009;30(5):616-625. https:\/\/doi.org\/10.1016\/j.immuni.2009.04.009","DOI":"10.1016\/j.immuni.2009.04.009"},{"issue":"1","key":"3892_CR63","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000080523","volume":"135","author":"A Taylor","year":"2004","unstructured":"Taylor A, Verhagen J, et al. T regulatory cells in allergy and health: A question of allergen specificity and balance. Int Arch Allergy Immunol. 2004;135(1):73\u201382. https:\/\/doi.org\/10.1159\/000080523.","journal-title":"Int Arch Allergy Immunol"},{"key":"3892_CR64","doi-asserted-by":"publisher","unstructured":"You S. Lymphatic-localized Treg-mregDC crosstalk limits antigen trafficking and restrains anti-tumor immunity, https:\/\/doi.org\/10.1016\/j.ccell.2024.06.014","DOI":"10.1016\/j.ccell.2024.06.014"},{"issue":"4","key":"3892_CR65","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nri1806","volume":"6","author":"W Zou","year":"2006","unstructured":"Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol. 2006;6(4):295\u2013307. https:\/\/doi.org\/10.1038\/nri1806.","journal-title":"Nat Rev Immunol"},{"key":"3892_CR66","doi-asserted-by":"publisher","unstructured":"Cinier J, et al. Recruitment and expansion of tregs cells in the tumor environment\u2014how to target them? Cancers. Apr. 2021;13(8):1850. https:\/\/doi.org\/10.3390\/cancers13081850","DOI":"10.3390\/cancers13081850"},{"key":"3892_CR67","doi-asserted-by":"publisher","unstructured":"Tay C et al. Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy, https:\/\/doi.org\/10.1016\/j.ccell.2023.02.014","DOI":"10.1016\/j.ccell.2023.02.014"},{"key":"3892_CR68","doi-asserted-by":"publisher","unstructured":"Chen X, et al. PD-1 regulates extrathymic regulatory T\u2010cell differentiation. Eur J Immunol. Sep. 2014;44(9):2603\u201316. https:\/\/doi.org\/10.1002\/eji.201344423.","DOI":"10.1002\/eji.201344423"},{"key":"3892_CR69","doi-asserted-by":"publisher","unstructured":"Amarnath S, et al. The PDL1-PD1 Axis converts human TH 1 cells into regulatory T cells. Sci Transl Med. Nov. 2011;3(111). https:\/\/doi.org\/10.1126\/scitranslmed.3003130.","DOI":"10.1126\/scitranslmed.3003130"},{"key":"3892_CR70","doi-asserted-by":"publisher","unstructured":"Wang Z, et al. Traditional Chinese medicine in regulating tumor microenvironment. OTT. Apr. 2024;17:313\u2013325. https:\/\/doi.org\/10.2147\/OTT.S444214","DOI":"10.2147\/OTT.S444214"},{"key":"3892_CR71","doi-asserted-by":"publisher","unstructured":"Ali Reza ASM, et al. Mechanistic insight into immunomodulatory effects of food-functioned plant secondary metabolites. Crit Rev Food Sci Nutr. Aug. 2023;63(22):5546\u20135576. https:\/\/doi.org\/10.1080\/10408398.2021.2021138","DOI":"10.1080\/10408398.2021.2021138"},{"key":"3892_CR72","doi-asserted-by":"publisher","unstructured":"Liang L, et al. Physalis alkekengi L. Var. Franchetii (Mast.) makino: A review of the pharmacognosy, chemical constituents, Pharmacological effects, quality control, and applications. Phytomedicine. Oct. 2022;105:154328. https:\/\/doi.org\/10.1016\/j.phymed.2022.154328.","DOI":"10.1016\/j.phymed.2022.154328"},{"key":"3892_CR73","doi-asserted-by":"publisher","unstructured":"Yang C, et al. Active ingredients of traditional Chinese medicine for enhancing the effect of tumor immunotherapy. Front Immunol. Mar. 2023;14:1133050. https:\/\/doi.org\/10.3389\/fimmu.2023.1133050.","DOI":"10.3389\/fimmu.2023.1133050"},{"key":"3892_CR74","doi-asserted-by":"publisher","unstructured":"Wen R, et al. Advances in traditional Chinese herbal medicine and their pharmacodynamic mechanisms in cancer immunoregulation: a narrative review. Transl Cancer Res. Feb. 2024;13(2):1166\u20131187. https:\/\/doi.org\/10.21037\/tcr-23-1983","DOI":"10.21037\/tcr-23-1983"},{"key":"3892_CR75","doi-asserted-by":"publisher","unstructured":"Checker R. et al. Plumbagin inhibits proliferative and inflammatory responses of T cells independent of ROS generation but by modulating intracellular thiols. J Cell Biochem. Aug. 2010;110(5):1082\u20131093. https:\/\/doi.org\/10.1002\/jcb.22620","DOI":"10.1002\/jcb.22620"},{"key":"3892_CR76","doi-asserted-by":"publisher","unstructured":"Checker R, et al. Anti-inflammatory effects of Plumbagin are mediated by Inhibition of NF-kappaB activation in lymphocytes. Int Immunopharmacol. Jul. 2009;9:7\u20138. https:\/\/doi.org\/10.1016\/j.intimp.2009.03.022.","DOI":"10.1016\/j.intimp.2009.03.022"},{"key":"3892_CR77","doi-asserted-by":"publisher","unstructured":"Zhang Z, et al. Plumbagin protects mice from lethal Sepsis by modulating immunometabolism upstream of PKM2. Mol Med. Jan. 2016;22(1):162\u201372. https:\/\/doi.org\/10.2119\/molmed.2015.00250.","DOI":"10.2119\/molmed.2015.00250"},{"key":"3892_CR78","doi-asserted-by":"publisher","unstructured":"Jia Y, et al. Amelioration of experimental autoimmune encephalomyelitis by Plumbagin through Down-Regulation of JAK-STAT and NF-\u03baB signaling pathways. PLoS ONE. Oct. 2011;6(10):e27006. https:\/\/doi.org\/10.1371\/journal.pone.0027006.","DOI":"10.1371\/journal.pone.0027006"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03892-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-025-03892-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-025-03892-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T11:58:42Z","timestamp":1752926322000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-025-03892-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,19]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3892"],"URL":"https:\/\/doi.org\/10.1186\/s12935-025-03892-x","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,19]]},"assertion":[{"value":"7 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The acquisition of patient tissues and clinicopathological data has been endorsed by the Human Ethics Committee of the First Affiliated Hospital of Nanchang University (2024CDYFYYLK07-008). The animal procedures were approved by the Animal Welfare Ethics Committee of the First Affiliated Hospital of Nanchang University (CDYFY-IACUC-202406QR027).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agreed with the submission of the manuscript for publication and agreed to be accountable for all aspects of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"271"}}